202 related articles for article (PubMed ID: 9412539)
1. Molecular and cellular mechanisms of myocardial failure.
Colucci WS
Am J Cardiol; 1997 Dec; 80(11A):15L-25L. PubMed ID: 9412539
[TBL] [Abstract][Full Text] [Related]
2. Subcellular remodeling as a viable target for the treatment of congestive heart failure.
Dhalla NS; Dent MR; Tappia PS; Sethi R; Barta J; Goyal RK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):31-45. PubMed ID: 16703218
[TBL] [Abstract][Full Text] [Related]
3. [Phenotype alterations of failing myocardium].
Takemura G; Fujiwara H
Nihon Rinsho; 2003 May; 61(5):731-8. PubMed ID: 12754995
[TBL] [Abstract][Full Text] [Related]
4. A look between the cardiomyocytes: the extracellular matrix in heart failure.
Miner EC; Miller WL
Mayo Clin Proc; 2006 Jan; 81(1):71-6. PubMed ID: 16438481
[TBL] [Abstract][Full Text] [Related]
5. The ageing spontaneously hypertensive rat as a model of the transition from stable compensated hypertrophy to heart failure.
Boluyt MO; Bing OH; Lakatta EG
Eur Heart J; 1995 Dec; 16 Suppl N():19-30. PubMed ID: 8682057
[TBL] [Abstract][Full Text] [Related]
6. Local neurohumoral regulation in the transition to isolated diastolic heart failure in hypertensive heart disease: absence of AT1 receptor downregulation and 'overdrive' of the endothelin system.
Yamamoto K; Masuyama T; Sakata Y; Doi R; Ono K; Mano T; Kondo H; Kuzuya T; Miwa T; Hori M
Cardiovasc Res; 2000 Jun; 46(3):421-32. PubMed ID: 10912453
[TBL] [Abstract][Full Text] [Related]
7. Post-infarction heart failure in the rat is associated with distinct alterations in cardiac myocyte molecular phenotype.
Yue P; Long CS; Austin R; Chang KC; Simpson PC; Massie BM
J Mol Cell Cardiol; 1998 Aug; 30(8):1615-30. PubMed ID: 9737947
[TBL] [Abstract][Full Text] [Related]
8. [Pathophysiology of cytoskeleton and extracellular matrix in failing myocardium].
Hori M; Sato H; Fukunami M; Houki N
Nihon Rinsho; 1993 May; 51(5):1191-7. PubMed ID: 8331786
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide in the failing myocardium.
Sawyer DB; Colucci WS
Cardiol Clin; 1998 Nov; 16(4):657-64, viii. PubMed ID: 9891595
[TBL] [Abstract][Full Text] [Related]
10. The effects of norepinephrine on myocardial biology: implications for the therapy of heart failure.
Colucci WS
Clin Cardiol; 1998 Dec; 21(12 Suppl 1):I20-4. PubMed ID: 9853191
[TBL] [Abstract][Full Text] [Related]
11. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathogenesis of myocardial remodeling and new potential therapeutic targets in chronic heart failure.
Distefano G; Sciacca P
Ital J Pediatr; 2012 Sep; 38():41. PubMed ID: 22971785
[TBL] [Abstract][Full Text] [Related]
13. Subcellular remodelling may induce cardiac dysfunction in congestive heart failure.
Dhalla NS; Saini-Chohan HK; Rodriguez-Leyva D; Elimban V; Dent MR; Tappia PS
Cardiovasc Res; 2009 Feb; 81(3):429-38. PubMed ID: 18852252
[TBL] [Abstract][Full Text] [Related]
14. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes.
Wohlschlaeger J; Schmitz KJ; Schmid C; Schmid KW; Keul P; Takeda A; Weis S; Levkau B; Baba HA
Cardiovasc Res; 2005 Dec; 68(3):376-86. PubMed ID: 16024006
[TBL] [Abstract][Full Text] [Related]
15. Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure.
Schram K; Sweeney G
Trends Cardiovasc Med; 2008 Aug; 18(6):199-205. PubMed ID: 19185809
[TBL] [Abstract][Full Text] [Related]
16. Molecular and cellular mechanisms of myocardial remodeling.
Maytin M; Colucci WS
J Nucl Cardiol; 2002; 9(3):319-27. PubMed ID: 12032480
[No Abstract] [Full Text] [Related]
17. Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system.
Grimm D; Elsner D; Schunkert H; Pfeifer M; Griese D; Bruckschlegel G; Muders F; Riegger GA; Kromer EP
Cardiovasc Res; 1998 Jan; 37(1):91-100. PubMed ID: 9539862
[TBL] [Abstract][Full Text] [Related]
18. [Interactions between cardiomyocytes and extracellular matrix in the failing human heart].
Schaper J; Mollnau H; Hein S; Scholz D; Münkel B; Devaux B
Z Kardiol; 1995; 84 Suppl 4():33-8. PubMed ID: 8585271
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of subcellular remodelling in post-infarct heart failure.
Dhalla NS; Kaura D; Liu X; Beamish RE
EXS; 1996; 76():463-77. PubMed ID: 8805812
[TBL] [Abstract][Full Text] [Related]
20. Heart failure, ventricular remodelling and the renin-angiotensin system: insights from recently completed clinical trials.
Young JB
Eur Heart J; 1993 Jul; 14 Suppl C():14-7. PubMed ID: 8365422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
